Potential benefit of pharmacological induction of beta common receptor

Slides:

Advertisements

Similar presentations

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Advertisements

Of mice and men and surgical transcatheter aortic valve insertion

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Manuel J. Antunes, MD, PhD, DSc

The eighth edition TNM stage classification for lung cancer: What does it mean on main street? Frank C. Detterbeck, MD The Journal of Thoracic and Cardiovascular.

“Lead from the front”: Participative leadership

Improving health care by embracing Systems Theory

Neel R. Sodha, MD, Frank W. Sellke, MD

Murray H. Kwon, MD The Journal of Thoracic and Cardiovascular Surgery

Intrinsic cardiac stem cells are essential for regeneration

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

Abracadabra I, II…HeartMate 3?

Victor van Berkel, MD, PhD

William M. DeCampli, MD, PhD

Functional mitral stenosis after mitral valve repair is a true anatomic problem that originates from the time of surgery Vincent Chan, MD, MPH, Thierry.

Go on-pump or off-pump in diabetic patients?

Bigger The Journal of Thoracic and Cardiovascular Surgery

The lord of the rings Antonio Miceli, MD, PhD

Aldo R. Castañeda, MD, PhD: Recipient of the Lifetime Achievement Award and 74th president of The American Association for Thoracic Surgery Pedro J.

The variability of the mitral valve anatomy and terminology

Leora B. Balsam, MD The Journal of Thoracic and Cardiovascular Surgery

Support Your Specialty

Innovation and science: The future of valve design

A fairy tale future for Fontans: Fact or fable?

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery Vinay Badhwar, MD The Journal of Thoracic and.

It's not “just a shunt” but sometimes it should be…

Fixing the supply problem

Military surgeons just want to have fun

Do we need a bibliometrician to know which way the wind is blowing?

A first start for lung transplantation?

Right ventricular failure after cardiac surgery: Why can't right ventricular assist device support fix the problem? Francis D. Pagani, MD, PhD The Journal.

Get it right the first time

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Is endoluminal vacuum therapy “sponge worthy”?

A fate worse than death Jennifer S. Lawton, MD

Attachment disorder in thoracoabdominal surgery

The Ross procedure: Time to reevaluate the guidelines

Video-assisted resection for lung cancer results in fewer complications Lunxu Liu, PhD, MD, FRCS The Journal of Thoracic and Cardiovascular Surgery

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Prognosis and “granularity”: Building on staging foundations?

Who is your plastic surgeon

James I. Fann, MD, John E. Connolly, MD

T. Brett Reece, MD The Journal of Thoracic and Cardiovascular Surgery

First nights, the adrenal axis, and steroids

The origins of open heart surgery at the University of Minnesota 1951 to 1956 Richard A. DeWall, MD The Journal of Thoracic and Cardiovascular Surgery

Early extubation after cardiac surgery: The evolution continues

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Tissue valve, nitinol stent, or storage solution

The future of cardiac surgery training: A survival guide

The continuing challenge of congenital heart disease in China

Bicuspid aortopathy: Seeing the forest for the trees

Ralph E. Delius, MD The Journal of Thoracic and Cardiovascular Surgery

The Journal of Thoracic and Cardiovascular Surgery

“The more things change…”: The challenges ahead

Evaluating the best approach to treatment of aortic stenosis: The jury is still out Glen B. Taksler, PhD The Journal of Thoracic and Cardiovascular Surgery

Toll-like receptor 4 inhibition attenuates ischemia-reperfusion injury in rats: Will it work in human beings? Chadrick E. Denlinger, MD The Journal.

Managing conflicts of interest

More than vital: Who bears the burden?

Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery Raja M. Flores, MD The Journal.

Respect the aorta The Journal of Thoracic and Cardiovascular Surgery

Preoperative PFTs: The answer is blowing in the wind

The evolution of cardiothoracic critical care

Of mice and men… The Journal of Thoracic and Cardiovascular Surgery

Did you like Terminator 3 better than Terminator 2

Journal changes and initiatives

Zone zero thoracic endovascular aortic repair is all about “location, location, location” Kevin L. Greason, MD The Journal of Thoracic and Cardiovascular.

Deciding how much to pay for effective care

Presentation transcript:

Potential benefit of pharmacological induction of beta common receptor Katsuhiro Yamanaka, MD, PhD, Mohamed Eldeiry, MD, Gavriel Roda, BS, Muhammad Aftab, MD, T. Brett Reece, MD The Journal of Thoracic and Cardiovascular Surgery Volume 156, Issue 5, Pages 1796-1797 (November 2018) DOI: 10.1016/j.jtcvs.2018.07.025 Copyright © 2018 Terms and Conditions

Figure 1 A time trial about beta common receptor (bcR) expression was carried out using diazoxide (DZ) given to mice by oral gavage. The expression of bcR was evaluated by western blot analysis. The expression of bcR was significantly upregulated 12 hours after administration of DZ and it peaked at 36 hours after administration of DZ. The Journal of Thoracic and Cardiovascular Surgery 2018 156, 1796-1797DOI: (10.1016/j.jtcvs.2018.07.025) Copyright © 2018 Terms and Conditions

The Journal of Thoracic and Cardiovascular Surgery 2018 156, 1796-1797DOI: (10.1016/j.jtcvs.2018.07.025) Copyright © 2018 Terms and Conditions